1. Home
  2. KD vs TMDX Comparison

KD vs TMDX Comparison

Compare KD & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kyndryl Holdings Inc.

KD

Kyndryl Holdings Inc.

N/A

Current Price

$11.64

Market Cap

2.8B

Sector

Technology

ML Signal

N/A

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

BUY

Current Price

$83.24

Market Cap

2.6B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
KD
TMDX
Founded
2020
1998
Country
United States
United States
Employees
80000
N/A
Industry
EDP Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.6B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
KD
TMDX
Price
$11.64
$83.24
Analyst Decision
Hold
Buy
Analyst Count
6
12
Target Price
$14.20
★ $97.30
AVG Volume (30 Days)
★ 3.8M
629.7K
Earning Date
11-03-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 382.18
EPS
N/A
★ 0.61
Revenue
★ $15,092,000,000.00
$605,494,000.00
Revenue This Year
N/A
$22.50
Revenue Next Year
N/A
$17.93
P/E Ratio
★ N/A
$128.92
Revenue Growth
0.23
★ 37.13
52 Week Low
$10.10
$60.11
52 Week High
$30.99
$156.00

Technical Indicators

Market Signals
Indicator
KD
TMDX
Relative Strength Index (RSI) 42.13 46.88
Support Level $11.14 $80.29
Resistance Level $12.77 $90.67
Average True Range (ATR) 0.55 3.79
MACD -0.07 -0.67
Stochastic Oscillator 23.86 44.10

Price Performance

Historical Comparison
KD
TMDX

About KD Kyndryl Holdings Inc.

Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: